| Nov 13 |
Eyenovia Inc (EYEN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
|
| Nov 13 |
Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript
|
| Nov 12 |
Eyenovia, Inc. (EYEN) Reports Q3 Loss, Misses Revenue Estimates
|
| Nov 12 |
Eyenovia GAAP EPS of -$0.11 in-line, revenue of $1.62M beats by $1.51M
|
| Nov 12 |
Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 11 |
Earnings Outlook For Eyenovia
|
| Nov 7 |
Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th
|
| Oct 23 |
Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet®
|
| Oct 16 |
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo
|
